James A. Geraghty

CIK: 0001239746

Transaction Breakdown

Open Market Buys (P)1 (16.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

FULC

Fulcrum Therapeutics, Inc.

Director

VYGR

Voyager Therapeutics, Inc.

Director

PIRS

PIERIS PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

FULC
Fulcrum Therapeutics, Inc.
Jun 30, 2026
Award(A)
Stock Option (right to buy)
Direct
32K shares-
VYGR
Voyager Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
FULC
Fulcrum Therapeutics, Inc.
Jun 26, 2025
Award(A)
Stock Option (right to buy)
Direct
36K shares-
VYGR
Voyager Therapeutics, Inc.
Jun 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
24K shares-
PIRS
PIERIS PHARMACEUTICALS, INC.
Dec 12, 2024
Disposition(D)
Direct
1 shares at avg. $0.01$0.01
PIRS
PIERIS PHARMACEUTICALS, INC.
Aug 7, 2024
Purchase(P)
Direct
1 shares at avg. $1.00$1

		Type	Shares	Price		Ownership
Jun 30, 2026	FULC Fulcrum Therapeutics, Inc.	Award(A) Stock Option (right to buy)	32,000	-	-	Direct
Jun 9, 2026	VYGR Voyager Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Jun 26, 2025	FULC Fulcrum Therapeutics, Inc.	Award(A) Stock Option (right to buy)	36,000	-	-	Direct
Jun 3, 2025	VYGR Voyager Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	24,000	-	-	Direct
Dec 12, 2024	PIRS PIERIS PHARMACEUTICALS, INC.	Disposition(D)	1	$0.01	$0	Direct
Aug 7, 2024	PIRS PIERIS PHARMACEUTICALS, INC.	Purchase(P)	1	$1.00	$1	Direct

1-6 of 6 transactions

About GERAGHTY JAMES A

GERAGHTY JAMES A (SEC CIK 0001239746) files insider reports with the SEC as Director of Fulcrum Therapeutics, Inc. (FULC), Director of Voyager Therapeutics, Inc. (VYGR) and Director of PIERIS PHARMACEUTICALS, INC. (PIRS).

Signal8 holds 6 ownership filings by GERAGHTY JAMES A, all Form 4s, filed between Oct 28, 2024 and Jul 2, 2026. Those filings report 6 transactions, from Aug 7, 2024 to Jun 30, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GERAGHTY JAMES A's filings is in CAMBRIDGE, MA.

Recent filings by GERAGHTY JAMES A

Jun 30, 2026: Grant or award of FULC derivative securities (Form 4, code A).
Jun 9, 2026: Grant or award of VYGR derivative securities (Form 4, code A).
Jun 26, 2025: Grant or award of FULC derivative securities (Form 4, code A).
Jun 3, 2025: Grant or award of VYGR derivative securities (Form 4, code A).
Dec 12, 2024: Disposition to issuer transaction of PIRS shares (Form 4, code D).

Other insiders filing for Fulcrum Therapeutics, Inc. (FULC)

TANG KEVIN, 10% Owner
Banks Sonja, Director
Dorton Katina, Director
Gould Robert J, Director
Haviland Kate, Director
King Rachel K., Director

How to read Form 4 transaction codes